hormonio glp-1 GLP-1: o biomarcador central da nova era da pesquisa metabólica em humanos e animais Glucagon-like peptide-1 receptor: mechanisms and
Description
A recent systematic review and meta-analysis (SRM) of nine RCTs that examined the cancer risk associated with tirzepatide has been published
June 26, 2025
There is no evidence that semaglutide suppresses the immune system or directly increases susceptibility to infections
Approximately 510% of PDAC develop from malignant transformation of a mucinous pancreatic cyst rather than through the PanIN pathway 53
Recent findings from the SUSTAIN-7 study demonstrated semaglutide's superiority over dulaglutide in enhancing glycaemic management and facilitating significant weight reduction, while preserving similar safety profiles (Pratley et al
Mindkt vllalat amellett rvelt, hogy a szjon t szedhet opcik egyre tbb embert vonzanak a fogykrs gygyszerek piacra, a Novo pedig azt hangoztatta, hogy a Wegovy tabletta receptjei mindssze t hnappal a bevezets utn elrtk a 3 millit
